Refractory Malignant Solid Neoplasm

specific

A malignant solid neoplasm that does not respond to treatment.

83

Centers

534

Active Trials

Cancer Funding

Top Centers for Refractory Malignant Solid Neoplasm(83)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.8
2
NCI Comprehensive
High-Volume Research Center
72.3
3
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
High-Volume Research Center
71.5
4
NCI Comprehensive
High-Volume Research Center
71.5
5
High-Volume Research Center
70.1
6
NCI Comprehensive
High-Volume Research Center
70.1
7
High-Volume Research Center
70.1
8
NCI Clinical
Active Research Program
67.1
9
NCI Comprehensive
Active Research Program
67.1
10
NCI Comprehensive
Active Research Program
67.1
11
NCI Comprehensive
Active Research Program
67.1
12
NCI Comprehensive
Active Research Program
67.1
1367.1
14
NCI Comprehensive
Active Research Program
67.1
15
Active Research Program
67.1
16
NCI Comprehensive
Active Research Program
64.7
17
NCI Comprehensive
Active Research Program
62.8
18
NCI Comprehensive
Active Research Program
62.8
19
NCI Comprehensive
Active Research Program
62.8
20
NCI Clinical
Active Research Program
62.8
21
NCI Comprehensive
Active Research Program
62.8
22
Active Research Program
62.8
23
Active Research Program
58.5
24
Active Research Program
58.5
25
NCI Comprehensive
Active Research Program
58.5
26
NCI Comprehensive
Active Research Program
58.5
27
NCI Comprehensive
Active Research Program
58.5
28
NCI Comprehensive
Active Research Program
58.5
29
NCI Clinical
Active Research Program
58.5
30
Active Research Program
58.5
3158.5
32
Active Research Program
58.5
33
Active Research Program
53.9
34
NCI Comprehensive
Active Research Program
53.9
35
Active Research Program
53.9
36
NCI Comprehensive
Active Research Program
53.9
37
NCI Comprehensive
Active Research Program
53.9
38
Active Research Program
53.9
3953.9
40
NCI Comprehensive
Active Research Program
51.1
41
NCI Comprehensive
Active Research Program
51.1
42
Active Research Program
51.1
43
NCI Comprehensive
Active Research Program
49.0
44
NCI Comprehensive
Active Research Program
49.0
45
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
49.0
46
NCI Clinical
Active Research Program
49.0
47
Active Research Program
49.0
48
NCI Comprehensive
Active Research Program
46.3
49
NCI Comprehensive
Active Research Program
46.3
50
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
46.3
51
NCI Comprehensive
Active Research Program
46.3
52
Active Research Program
46.3
53
Active Research Program
44.4
54
Active Research Program
44.4
55
NCI Comprehensive
Active Research Program
43.6
56
NCI Comprehensive
Active Research Program
42.7
57
NCI Comprehensive
Active Research Program
42.7
58
NCI Comprehensive
Active Research Program
35.4
59
NCI Comprehensive
Active Research Program
35.4
60
NCI Comprehensive
Active Research Program
35.4
61
NCI Comprehensive
Active Research Program
35.4
62
NCI Comprehensive
Active Research Program
35.4
63
NCI Comprehensive
Active Research Program
35.4
64
NCI Comprehensive
Active Research Program
35.4
65
NCI Comprehensive
Active Research Program
35.4
66
NCI Comprehensive
Active Research Program
35.4
67
NCI Comprehensive
Active Research Program
35.4
68
NCI Comprehensive
Active Research Program
35.4
69
NCI Comprehensive
Active Research Program
35.4
70
NCI Comprehensive
Active Research Program
35.4
71
NCI Comprehensive
Active Research Program
35.4
72
NCI Comprehensive
Active Research Program
35.4
73
NCI Comprehensive
Active Research Program
35.4
74
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
35.4
75
Active Research Program
35.4
76
NCI Basic_laboratory
Active Research Program
35.4
77
Active Research Program
35.4
78
Active Research Program
35.4
79
Active Research Program
35.4
80
Active Research Program
35.4
81
Active Research Program
35.4
82
Active Research Program
35.4
83
BC CancerVancouver, BC
28.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →